Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 8 Liver Neoplasms 5 Carcinoma, Hepatocellular 4 Lung Neoplasms 3 Squamous Intraepithelial Lesions 2 Prostatic Neoplasms 2 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Unresectable Pancreatic Cancer 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Rectal Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Neoplasm Metastasis 1 Melanoma 1 Lymphatic Metastasis 1 Liver, Cancer of, Non-Resectable 1 Laryngeal Neoplasms 1 Hilus Pulmonary Neoplasms 1 Head and Neck Neoplasms 1 HIV Seropositivity 1 Gallbladder Neoplasms 1 Extremities Neoplasms 1 Esophageal Neoplasms 1 Colorectal Liver Metastases 1 Carcinoma, Renal Cell 1

Interventions

Cisplatin 12 Radiotherapy 10 Cetuximab 9 Fluorouracil 6 Drug Therapy 5 Docetaxel 5 pembrolizumab 3 Radiotherapy, Intensity-Modulated 3 Radiation 3 Laser Therapy 3 Hydroxyurea 3 sargramostim 2 Surveys and Questionnaires 2 Resistance Training 2 Psychiatric Rehabilitation 2 Nutritional Status 2 Nicotine 2 Counseling 2 Celecoxib 2 Carboplatin 2 Bupropion 2 Bronchoscopy 2 sodium thiosulfate 1 motexafin gadolinium 1 gossypol acetic acid 1 durvalumab 1 adavosertib 1 Zinc Oxide 1 Varenicline 1 Transcutaneous Electric Nerve Stimulation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Laryngeal Neoplasms × Electroporation × Clear all

NCT02430675 2021-09-05

IRE

Fuda Cancer Hospital, Guangzhou

Phase NA Completed

Laryngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡